[go: up one dir, main page]

ES528121A0 - Un metodo de produccion de una preparacion de proteina a-igg - Google Patents

Un metodo de produccion de una preparacion de proteina a-igg

Info

Publication number
ES528121A0
ES528121A0 ES528121A ES528121A ES528121A0 ES 528121 A0 ES528121 A0 ES 528121A0 ES 528121 A ES528121 A ES 528121A ES 528121 A ES528121 A ES 528121A ES 528121 A0 ES528121 A0 ES 528121A0
Authority
ES
Spain
Prior art keywords
protein
production method
igg preparation
igg
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES528121A
Other languages
English (en)
Other versions
ES8601703A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of ES528121A0 publication Critical patent/ES528121A0/es
Publication of ES8601703A1 publication Critical patent/ES8601703A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6851Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES528121A 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg Expired ES8601703A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36643682A 1982-04-07 1982-04-07
US47236283A 1983-03-11 1983-03-11

Publications (2)

Publication Number Publication Date
ES528121A0 true ES528121A0 (es) 1985-11-01
ES8601703A1 ES8601703A1 (es) 1985-11-01

Family

ID=27003359

Family Applications (5)

Application Number Title Priority Date Filing Date
ES521279A Granted ES521279A0 (es) 1982-04-07 1983-04-06 Una inmunopreparacion tumoral.
ES528120A Granted ES528120A0 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de plasma activada con zymosan
ES528119A Expired ES8503954A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg
ES528121A Expired ES8601703A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg
ES528118A Granted ES528118A0 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de inmunoglobulina tumoral

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES521279A Granted ES521279A0 (es) 1982-04-07 1983-04-06 Una inmunopreparacion tumoral.
ES528120A Granted ES528120A0 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de plasma activada con zymosan
ES528119A Expired ES8503954A1 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de proteina a-igg

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES528118A Granted ES528118A0 (es) 1982-04-07 1983-12-16 Un metodo de produccion de una preparacion de inmunoglobulina tumoral

Country Status (13)

Country Link
EP (1) EP0091784B1 (es)
AU (2) AU569467B2 (es)
CA (1) CA1230555A (es)
DE (1) DE3374756D1 (es)
DK (1) DK154283A (es)
ES (5) ES521279A0 (es)
FI (1) FI831169L (es)
GB (2) GB2119803B (es)
GR (1) GR78514B (es)
NO (5) NO831223L (es)
PT (1) PT76505B (es)
RO (3) RO89496A (es)
ZW (1) ZW7583A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161813B (en) * 1984-07-20 1988-07-13 Michiko Koga Anti-tumor agent
GB9013872D0 (en) * 1990-06-21 1990-08-15 Inst Tecnologico Y Cientifico Use of protein a and polypeptide components thereof in the treatment of tumours
AU6498494A (en) * 1993-04-08 1994-11-08 Board Of Regents, The University Of Texas System Model for gonococcal infection
GB2422311A (en) * 2005-01-20 2006-07-26 Martin Lister Treatment of blood to cure disease
DE102005012594A1 (de) 2005-03-18 2006-09-21 Bayer Technology Services Gmbh Elektrofiltrationsverfahren
AU2010248833B2 (en) * 2009-05-14 2015-08-20 Oatmeal Biotechnologies Group, L.L.C. Platform technologies for spontaneously occurring diseases
EP4353320B1 (en) * 2016-04-28 2025-06-18 Alkahest, Inc. Blood plasma and plasma fractions as therapy for tumor growth and progression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
FI791551A7 (fi) * 1978-05-17 1981-01-01 As Alfred Benzon Puhdistettu syöpäassosioitunut proteiini.

Also Published As

Publication number Publication date
AU569467B2 (en) 1988-02-04
ES8405621A1 (es) 1984-06-16
NO841497L (no) 1983-10-10
DE3374756D1 (en) 1988-01-14
AU1286583A (en) 1983-10-13
GR78514B (es) 1984-09-27
RO89498A (ro) 1986-06-30
FI831169A7 (fi) 1983-10-08
ES8503950A1 (es) 1985-04-16
GB2163164B (en) 1986-09-03
ES528120A0 (es) 1985-04-16
EP0091784B1 (en) 1987-12-02
RO89496A (ro) 1986-06-30
CA1230555A (en) 1987-12-22
NO841498L (no) 1983-10-10
ES8503953A1 (es) 1985-04-16
RO86661B (ro) 1985-03-01
EP0091784A3 (en) 1984-07-11
EP0091784A2 (en) 1983-10-19
PT76505B (en) 1986-05-05
DK154283D0 (da) 1983-04-07
RO86661A (ro) 1986-07-30
NO831223L (no) 1983-10-10
FI831169L (fi) 1983-10-08
DK154283A (da) 1983-10-08
AU1560088A (en) 1988-10-27
NO841495L (no) 1983-10-10
FI831169A0 (fi) 1983-04-06
ES521279A0 (es) 1984-06-16
NO841496L (no) 1983-10-10
ES8601703A1 (es) 1985-11-01
GB2119803B (en) 1986-09-03
GB8309348D0 (en) 1983-05-11
ES528119A0 (es) 1985-04-16
GB2163164A (en) 1986-02-19
GB2119803A (en) 1983-11-23
GB8510892D0 (en) 1985-06-05
ZW7583A1 (en) 1983-06-29
ES528118A0 (es) 1985-04-16
PT76505A (en) 1983-05-01
ES8503954A1 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
ES537994A0 (es) Un metodo de producir una proteina de interleuquina-2-humana no glicosilada sustancialmente pura
ES523927A0 (es) Un metodo de fabricar un bizcocho
ES531898A0 (es) Procedimiento para obtener una proteina heterologa para levadura
ES500684A0 (es) Metodo para la preparacion de una poliamida
RO89963A (ro) Procedeu pentru prepararea unor difluoronucleozide
ES527414A0 (es) Un metodo de producir una proteina interferon inmune humano
ES522951A0 (es) Un metodo de fabricar un tejido recubierto estabilizado
ES541572A0 (es) Un metodo de fabricar una camisa de valvula
ES522272A0 (es) Metodo de fabricacion de cierres de cremallera
ES532509A0 (es) Un metodo de preparar dihidrobenzopirrolbenzodiazepinas
ES531897A0 (es) Procedimiento para obtener una proteina heterologa para levaduras
IT1174195B (it) Albero a camme e procentimento per la sua fabbricazione
MX156049A (es) Un procedimiento para la preparacion de una n - piperazinilalcanolanilida
ES504018A0 (es) Un metodo de fabricar una disposicion de interconexion elec-trica
ES523190A0 (es) Un metodo de preparar derivados de 4-quinolona
ES528119A0 (es) Un metodo de produccion de una preparacion de proteina a-igg
ES548109A0 (es) Un metodo de preparacion de n,n-di-n-propil-4-hidroxi-3- metanosulfonamido-fenetilamina
RO93446A (ro) Procedeu de preparare a interferonului
ES525656A0 (es) Un metodo de preparar profarmacos de pilocarpina
ES530184A0 (es) Metodo de producir una preparacion yodofora farmaceutica
RO90519A (ro) Procedeu de preparare a clorotioformiatilor
ES503801A0 (es) Un metodo de fabricacion de una pelicula orientada biaxial- mente
ES529348A0 (es) Metodo de fabricacion de cierres de cremallera
RO88722A (ro) Procedeu pentru prepararea unor 22-eteri-hexanorbrasinolid
ES549525A0 (es) Un metodo para producir una proteina heterologa